454 sequencing identifies early stage HIV drug resistance March 13, 2009 – Retrospective research study shows that even the lowest levels of resistance mutations could lead to early treatment failure. A research study published online in the Journal of Infectious Disease reports that HIV resistance mutations present in as little as 1% of the viral population have a significant impact on clinical outcomes. more NextGen Sciences divests electrophoresis business to Sigma-Aldrich March 04, 2009 – NextGen Sciences, the provider of biomarker discovery, assay development and testing services, has sold its electrophoresis business to Sigma-Aldrich Corporation. NextGen Sciences will receive a cash payment and royalty payments on revenues for three years. more Eurofins is the first to provide testing of pesticides and melamine to European standards in China January 26, 2009 – Eurofins' new food testing laboratory in Suzhou, near Shanghai, China is the first facility in that country to have developed capabilities for testing pesticides and melamine/cyanuric acid that are approved by and identical to the latest European standards of testing available at its Competence Centres, Eurofins Dr. Specht and WEJ, based in Hamburg, Germany. more GE Healthcare introduces Biacore T100 Immunogenicity Package Oktober 20, 2008 – GE Healthcare published that it is has introduced a new immunogenicity software package for its Biacore T100 label-free protein interaction analysis system, to support screening, confirmation and characterization of anti-drug antibodies during preclinical and clinical development. more
